MedPath

CLONAZEPAM

CLONAZEPAM

Discontinued
DIN Number

02442035

Drug Class

Human

Market Date

Jul 9, 2015

Company
HC

sivem pharmaceuticals ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02442035
AIG Number0111558001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N03AE01 CLONAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLONAZEPAMActive
Strength: 0.5 MG
Monograph: CLONAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.